References

1. Bates S. Fairfax man accused of anthrax threat. Washington Post. March 3, 1992;C.

2. Breman JG, Henderson DA. Poxvirus dilemmas--monkeypox, smallpox, and biologic terrorism. N Engl J Med. Aug 20 1998;339(8):556-9. [Medline].

3. CDC. Bioterrorism alleging use of anthrax and interim guidelines for management--United States, 1998. MMWR Morb Mortal Wkly Rep. Feb 5 1999;48(4):69-74. [Medline].

4. Christopher GW, Cieslak TJ, Pavlin JA, Eitzen EM. Biological warfare. A historical perspective. JAMA. Aug 6 1997;278(5):412-7. [Medline].

5. Danzig R, Berkowsky PB. Why should we be concerned about biological warfare?. JAMA. Aug 6 1997;278(5):431-2. [Medline].

6. Dixon TC, Meselson M, Guillemin J, Hanna PC. Anthrax. N Engl J Med. Sep 9 1999;341(11):815-26. [Medline].

7. Ferguson JR. Biological weapons and US law. JAMA. Aug 6 1997;278(5):357-60. [Medline].

8. Franz DR, Jahrling PB, Friedlander AM, McClain DJ, Hoover DL, Bryne WR. Clinical recognition and management of patients exposed to biological warfare agents. JAMA. Aug 6 1997;278(5):399-411. [Medline].

9. Harteveld JL, Nieuwenhuizen MS, Wils ER. Detection of staphylococcal enterotoxin B employing a piezoelectric crystal immunosensor. Biosens Bioelectron. 1997;12(7):661-7. [Medline].

10. Headquarters, Department of the Army. Treatment of Biological Warfare Agent Casualties. Washington, DC: Dept of the Army; July 2000.

11. Henderson DA. The looming threat of bioterrorism. Science. Feb 26 1999;283(5406):1279-82. [Medline].

12. Holloway HC, Norwood AE, Fullerton CS, Engel CC, Ursano RJ. The threat of biological weapons. Prophylaxis and mitigation of psychological and social consequences. JAMA. Aug 6 1997;278(5):425-7. [Medline].

13. Inglesby TV, Henderson DA, Bartlett JG, Ascher MS, Eitzen E, Friedlander AM. Anthrax as a biological weapon: medical and public health management. Working Group on Civilian Biodefense. JAMA. May 12 1999;281(18):1735-45. [Medline].

14. Kadlec RP, Zelicoff AP, Vrtis AM. Biological weapons control. Prospects and implications for the future. JAMA. Aug 6 1997;278(5):351-6. [Medline].

15. Kaufmann AF, Meltzer MI, Schmid GP. The economic impact of a bioterrorist attack: are prevention and postattack intervention programs justifiable?. Emerg Infect Dis. Apr-Jun 1997;3(2):83-94. [Medline].

16. Keim M, Kaufmann AF. Principles for emergency response to bioterrorism. Ann Emerg Med. Aug 1999;34(2):177-82. [Medline].

17. Lebeda FJ. Deterrence of biological and chemical warfare: a review of policy options. Mil Med. Mar 1997;162(3):156-61. [Medline].

18. Lederberg J. Infectious disease and biological weapons. Prophylaxis and mitigation. JAMA. Aug 6 1997;278(5):435-6. [Medline].

19. McGovern TW, Christopher GW, Eitzen EM. Cutaneous manifestations of biological warfare and related threat agents. Arch Dermatol. Mar 1999;135(3):311-22. [Medline].

20. Meselson M, Guillemin J, Hugh-Jones M, Langmuir A, Popova I, Shelokov A. The Sverdlovsk anthrax outbreak of 1979. Science. Nov 18 1994;266(5188):1202-8. [Medline].

21. Mobley JA. Biological warfare in the twentieth century: lessons from the past, challenges for the future. Mil Med. Nov 1995;160(11):547-53. [Medline].

22. Okumura T, Takasu N, Ishimatsu S, Miyanoki S, Mitsuhashi A, Kumada K. Report on 640 victims of the Tokyo subway sarin attack. Ann Emerg Med. Aug 1996;28(2):129-35. [Medline].

23. Pearson GS. The complementary role of environmental and security biological control regimes in the 21st century. JAMA. Aug 6 1997;278(5):369-72. [Medline].

24. Pesik N, Keim M, Sampson TR. Do US emergency medicine residency programs provide adequate training for bioterrorism?. Ann Emerg Med. Aug 1999;34(2):173-6. [Medline].

25. Pile JC, Malone JD, Eitzen EM, Friedlander AM. Anthrax as a potential biological warfare agent. Arch Intern Med. Mar 9 1998;158(5):429-34. [Medline].

26. Richards CF, Burstein JL, Waeckerle JF, Hutson HR. Emergency physicians and biological terrorism. Ann Emerg Med. Aug 1999;34(2):183-90. [Medline].

27. Robertson AG, Robertson LJ. From asps to allegations: biological warfare in history. Mil Med. Aug 1995;160(8):369-73. [Medline].

28. Sidell FR, Takafuji ET, Franz DR. Textbook of Military Medicine. Part I: Warfare, Weaponry, and the Casualty: Medical Aspects of Chemical and Biological Warfare. Washington, DC: TMM Publications, Borden Institute.

29. Stephenson J. Pentagon-funded research takes aim at agents of biological warfare. JAMA. Aug 6 1997;278(5):373-5. [Medline].

30. Tucker JB. National health and medical services response to incidents of chemical and biological terrorism. JAMA. Aug 6 1997;278(5):362-8. [Medline].

31. Torok TJ, Tauxe RV, Wise RP, Livengood JR, Sokolow R, Mauvais S. A large community outbreak of salmonellosis caused by intentional contamination of restaurant salad bars. JAMA. Aug 6 1997;278(5):389-95. [Medline].

32. US Army Medical Research Institute of Infectious Disease. Medical Management of Biological Casualties Handbook. 4^th ed. Frederick, Md: Fort Detrick: 2000.

33. Wiener SL. Strategies for the prevention of a successful biological warfare aerosol attack. Mil Med. May 1996;161(5):251-6. [Medline].

34. Zajtchuk R, Bellamy RD, eds. Textbook of Military Medicine: Medical Aspects of Chemical and Biological Warfare, Part 1. Washington, DC: Office of the Surgeon General; 1997.

35. Zydowicz D. Anthrax: a disease from antiquity visits the modern world. Minn Med. Jul 1998;81(7):19-20. [Medline].